文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

伤前抗凝对创伤性脑损伤患者预后的意义:系统评价与荟萃分析

Prognostic significance of preinjury anticoagulation in patients with traumatic brain injury: A systematic review and meta-analysis.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论伤前抗凝的TBI患者总体死亡风险约为未抗凝者的2.4倍,需针对性分诊与创伤团队激活。

伤前抗凝与更高的总体死亡率(OR 2.39,95%CI 1.63-3.50)、院内死亡率(OR 2.47,95%CI 1.56-3.93)及更长的ICU住院时间(均数差1.06,95%CI 0.54-1.57)相关。住院时间、需神经外科手术及出院回家比例两组无统计学差异。结论提示伤前抗凝是TBI患者死亡的强预后因素,需考虑更早干预和更积极影像检查的分诊与创伤团队激活方案。

要点

  • 伤前抗凝的TBI患者总体死亡风险约为未抗凝者的2.4倍(OR 2.39,95%CI 1.63-3.50,p<0.00001)。
  • 院内死亡率同样升高:伤前抗凝组OR 2.47(95%CI 1.56-3.93,p=0.0001)。
  • ICU住院时间更长:均数差1.06(95%CI 0.54-1.57,p<0.0001),伤前抗凝组更长。
  • 住院时间(均数差-2.15,95%CI -5.36至1.05,p=0.19)、需神经外科手术(OR 1.30,95%CI 0.70-2.44,p=0.41)、出院回家(OR 0.76,95%CI 0.55-1.04,p=0.09)两组无统计学差异。
  • 直接口服抗凝药与华法林的预后意义孰优孰劣,原文指出仍无答案。

适用人群与场景

  • 原文未提及具体纳入/排除标准及急诊/ICU/院前场景。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及具体处置流程或药物剂量;结论仅提出需专门的分诊与创伤团队激活方案,考虑更早干预和更积极影像检查(all anticoagulated patients)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 主要终点总体死亡率:伤前抗凝组高于无伤前抗凝组,OR 2.39(95%CI 1.63-3.50,p<0.00001)。
  • 次要终点院内死亡率:伤前抗凝组高于无伤前抗凝组,OR 2.47(95%CI 1.56-3.93,p=0.0001)。
  • 次要终点ICU住院时间:伤前抗凝组较无伤前抗凝组长,均数差1.06(95%CI 0.54-1.57,p<0.0001)。
  • 次要终点住院时间:两组无统计学差异,均数差-2.15(95%CI -5.36至1.05,p=0.19)。
  • 次要终点需神经外科手术:两组无统计学差异,OR 1.30(95%CI 0.70-2.44,p=0.41)。
  • 次要终点出院回家:两组无统计学差异,OR 0.76(95%CI 0.55-1.04,p=0.09)。
  • 所有结局数据采用随机效应模型分析。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析(观察性研究),证据等级 level III。
  • 注册号CRD42020192323,遵循PRISMA与MOOSE标准。
  • 原文未述局限性;原文指出直接口服抗凝药与华法林的预后意义仍无答案。

对床旁实践的改变

  • 伤前抗凝的TBI患者死亡风险更高,提示需专门的分诊与创伤团队激活方案,考虑更早干预和更积极影像检查(all anticoagulated patients)。
  • 原文未提及具体适用/不适用人群、常见陷阱。

指南或共识出处

  • Prognostic significance of preinjury anticoagulation in patients with traumatic brain injury: A systematic review and meta-analysis(J Trauma Acute Care Surg)

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) is a leading cause of injury-related deaths and neurological disability globally. Considering the widespread anticoagulant use among the aging population, we aimed to perform a systematic review and meta-analysis to evaluate the prognostic significance of preinjury anticoagulation in TBI patients.

METHODS: This systematic review was conducted according to a predefined protocol (International Prospective Register of Systematic Reviews CRD42020192323). In compliance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology standards, a structured electronic database search was undertaken to identify all observational studies comparing preinjury anticoagulation with no preinjury anticoagulation in TBI patients. The primary outcome measure was overall mortality. The secondary outcome measures comprised in-hospital mortality, length of hospital stay, length of intensive care unit stay, need for neurosurgical procedure, and number of patients discharged home. All outcome data were analyzed using random effects modeling.

RESULTS: Twelve comparative studies enrolling a total of 4,417 patients were included. Preinjury anticoagulation was associated with higher risk of overall mortality (odds ratio [OR], 2.39; 95% confidence interval [CI], 1.63-3.50, p < 0.00001), in-hospital mortality (OR, 2.47; 95% CI, 1.56-3.93, p = 0.0001), and longer length of intensive care unit stay (mean difference, 1.06; 95% CI, 0.54-1.57; p < 0.0001) compared with no preinjury anticoagulation. No statistical difference was observed in length of hospital stay (mean difference, -2.15; 95% CI, -5.36 to 1.05, p = 0.19), need for neurosurgical procedure (OR, 1.30; 95% CI, 0.70-2.44; p = 0.41), and discharged home (OR, 0.76; 95% CI, 0.55-1.04; p = 0.09) between the two groups.

CONCLUSION: Preinjury anticoagulation is a powerful prognosticator of mortality in TBI patients. This highlights the need for dedicated triage and trauma team activation protocols considering earlier intervention and more aggressive imaging in all anticoagulated patients. Future studies should focus on strategies that can potentially reduce the risk of mortality in this population. The prognostic significance of direct oral anticoagulants versus warfarin remains unanswered.

LEVEL OF EVIDENCE: Systematic review and meta-analysis of observational studies, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Lim XT, Ang E, Lee ZX, et al. Prognostic significance of preinjury anticoagulation in patients with traumatic brain injury: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2021. PMID: 33048909. doi:10.1097/TA.0000000000002976

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。